LEAN Cell and Gene Boston Summit

Despite tremendous scientific progress, stunning clinical results, and a slew of commercial approvals, this paradigm shifting industry finds itself facing an increasingly oppressive macro-economic climate.

Public and private investment in CGT is trending downwards to decade lows. Pipelines and workforces are being slashed at increasing rates. Input costs are expected to rise as world leaders erect trade barriers and protectionist policies putting more pressure on supply chains and balance sheets.

Strategically taking place one day before the flagship 10th CAR-TCR summit, the first of this event series aims to usher in a renaissance for CGT developers and manufacturers by helping you (re)discover LEAN concepts, knowledge, practices, and methods for how to systematically identify and eliminate waste, build a culture of continuous improvement, and drive operational excellency no matter where in the development cycle you are, so that we can deliver advanced therapies just-in-time to all patients.


URLs:
Website: https://go.evvnt.com/3143721-0?pid=2874
Brochure: https://go.evvnt.com/3143721-3?pid=2874

Category: Conferences | Science, Health and Medicine | Pharmaceuticals

Speakers: Ignacio Nunez, Chief Operations Officer, Cell Ready LLC, Mamta Kalra, Vice President CMC, Immatics N.V., Adam Beebe, Manager GMP Cell Production, Seattle Children's Therapeutics, Steve Feldman, Site Head and Scientific Director, Stanford University, Fred Parietti, Chief Executive Officer, Multiply Labs, Matt Hewitt, Vice President Chief Technology Officer Manufacturing Business Division, Charles River Laboratories